Parkinsonism Induced by Solvent Abuse
Ann NEurol 35:616-618, Uitti,R.J.,et al, 1994
Sumatriptan
Lancet 341:221-224, Bateman,D.N., 1993
A Clinicopathologic Study of 100 Cases of Parkinson's Disease
Arch Neurol 50:140-148, Hughes,A.J.,et al, 1993
Neurocognitive Dysfunction in the Eosinophilia-Myalgia Syndrome
Neurol 43:931-936, Krupp,L.B.,et al, 1993
Sumatriptan and Chest Pain
Lancet 341:1564-1565, Hillis,W.S.&MacIntyre,P.D., 1993
Transmural Myocardial Infarction with Sumatriptan
Lancet 341:861-862, Ottervanger,J.P.,et al, 1993
Efficacy of Subcutaneous Sumatriptan in Repeated Episodes of Migraine
Neurol 43:1363-1368, Cady,R.K.,et al, 1993
Comparisons of Therapeutic Effects of Levodopa
Levodopa & Selegiline, & Bromocriptine in Pts with Early, Mild Parkinson's, Parkinson's Res Grp in U, , BMJ 372,1993., 1993
Levodopa, Melanoma, and Parkinson's Disease
Neurol 43:674-677, Weiner,W.J.,et al, 1993
Clinical Experience with Controlled-Release Carbidopa/Levodopa in Parkinson's Disease
Neurol 43:677-681, Pahwa,R.,et al, 1993
Levodopa Improves Spatial Contrast Sensitivity in Parkinson's Disease
Arch Neurol 50:721-724, Hutton,J.T.,et al, 1993
The Spectrum of Levodopa-Related Fluctuations in Parkinson's Disease
Neurol 43:1459-1464, Riley,D.E.&Lang,A.E., 1993
Blood Levodopa Levels and Unified Parkinson's Disease Rating Scale Function:With and Without Exercise
Neurol 43:1040-1042, Goetz,C.G.,et al, 1993
Drug Therapy of Migraine
NEJM 329:1476-1483, Welch,K.M.A., 1993
Evidence for a Dopaminergic Deficit in Sporadic Amyoptrophic Lateral Sclerosis on Positron Emission Scanning
Lancet 324:1016-1018, Takahashi,H.,et al, 1993
Postmarketing Study of Cardiovascular Adverse Reactions Associated with Sumatriptan
BMJ 307:1185, Ottervanger,J.P.,et al, 1993
Dopaminergic Treatment of Restless Legs and Rebound Phenomenon
Neurol 43:455, Guilleminault,C.,et al, 1993
Sumatriptan:Efficacy and Contribution to Migraine Mechanisms
JNNP 55:1103-1105, Pearce,J.M.S., 1992
Olanzapine in the Treatment of Dopaminomimetic Psychosis in Patients with Parkinson's Disease
Neurol 47:1085-1087, Wolters,W.Ch.,et al, 1992
Periodic Triphasic Waves in Levodopa-Induced Encephalopathy
Neurol 42:444-446, Neufeld,M.Y., 1992
123I-iodobenzamide-SPECT Predicts Dopaminergic Responsiveness in patients with De Dovo Parkinsonism
Neurol 42:556-561, Schwarz,J.,et al, 1992
Gerstmann's Syndrome
Arch Neurol 49:445-447, Benton,A.L., 1992
Treatment of Migraine
Lancet 339:1207-1209, Lance,J.W., 1992
Eosinophilia-Myalgia Syndrome, Natural History in a Population-Based Cohort
Arch Int Med 152:1889-1892, Hedberg,K.,et al, 1992
Chronic Demyelinating Polyneuropathy Associated with Eosinophilia-Myalgia Syndrome
JNNP 55:352-358, Freimer,M.L.,et al, 1992
Coronary Vasospasm Induced by Subcutaneous Sumatriptan
BMJ 304:1415, Willett,F.,et al, 1992
Levodopa-Nonresponsive Lewy Body Parkinsonism:Clinicopathologic Study of Two Cases
Neurol 42:1323-1327, Mark,M.H.,et al, 1992
Sumatriptan for Migraine
The Medical Letter, 34:91-931992., , 1992
Dose Ranging Efficacy & Safety of Subcut Sumatriptan in Acute Treat of Migraine
Arch Neurol 49:1271-1276, Mathew,N.T.,et al, 1992
The Effect of Exercise on Levodopa Absorption
Neurol 42:2042-2045, Carter,J.H.,et al, 1992
Apomorphine Test for Dopaminergic Response in Pts with Previously Untreated Parkinson's
Arch Neurol 49:1131-1134, Gasser,T.,et al, 1992
The Cause and pathogenesis of the Eosinophilia-Myalgia Syndrome
Ann Int Med 116:140-147, Varga,J.,et al, 1992
Eosinophilia-Myalgia Syndrome in L-Tryptophan-Exposed Patients
JAMA 267:77-82, Kamb,M.L.,et al, 1992
Acute Encephalopathy Associated with the Eosinophilia-Myalgia Syndrome
Neurol 42:461-462, Adair,J.C.,et al, 1992
Multifocal Inflammatory Leukoencephalopathy with 5-Fluorouracil and Levamisole
Ann Neurol 31:262-267, Hook,C.C.,et al, 1992
Sumatriptan
Serotonin, Migraine, and Money, Editorial, Lancet 339:151-1522., , 1992
Deprenyl Effects of Levodopa Pharmacodynamics, Mood, and Free Radical Scavenging
Neurol 42:541-544, Baronti,F.,et al, 1992
Does Ageing Aggravate Parkinsonisn Disability?
JNNP 54:780-782, Blin,J.,et al, 1991
Oral Sumatriptan in Acute Migraine
Lancet 338:782-783, Goadsby,P.J.,et al, 1991
Sumatriptan in Migraine, May be Better than Aspirin and Metoclopramide
BMJ 303:1491, Pearce,J.M.S., 1991
Treatment of Acute Migraine with Subcutaneous Sumatriptan
JAMA 265:2831-2835, Cady,R.K.,et al, 1991
Treatment of Migraine Attacks with Sumatriptan
The Subcutaneous Sumatriptan International Study Group, NEJM 325:316-321, 353-354991., , 1991
Migraine Pain Associated with Middle Cerebral Artery Dilatation:Reversal by Sumatriptan
Lancet 338:13-17, Friberg,L.,et al, 1991
Treatment of Acute Cluster Headache with Sumatriptan
The Sumatriptan Cluster Headache Study Group, NEJM 325:322-326, 353-354991., , 1991
Standard & Controlled-Release Levodopa/Carbidopa in Fluctuating Parkinson's Disease on a Protein Redistribution Diet
Arch Neurol 48:402-405, Karstaedt,P.J.,et al, 1991
Neuroleptic Malignant Synd in Parkinson's after Withdrawal or Alteration of Dopaminergic Therapy
Arch Int Med 151:794-796, Keyser,D.L.&Rodnitzky,R.L., 1991
Controlled-Release Delivery of L-Dopa Associated with Nonfatal Hyperthermia, Rigidity, and Autonomic Dysfunction
Neurol 41:942-943, Cunningham,M.A.,et al, 1991
Long-term Acetyl-L-Carnitine Treatment in Alzheimer's Disease
Neurol 41:1726-1732, Spagnoli,A.,et al, 1991
Eosinophilia-Myalgia Syndrome, A Clinical Case Series of 21 Patients
Arch Int Med 151:533-537, Philen,R.M.,et al, 1991
Eosinophilia-Myalgia Syndrome Associated with Ingestion of L-Tryptophan:Muscle Biopsy Findings in 4 Patients
Neurol 41:319-321, Hollander,D.&Adelman,L.S., 1991